Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 7 de 7
1.
Int Immunopharmacol ; 132: 112030, 2024 May 10.
Article En | MEDLINE | ID: mdl-38603861

Mast cells (MCs) play a significant role in various diseases, and their activation and degranulation can trigger inflammatory responses and barrier damage. Several studies have indicated that vagus nerve stimulation (VNS) exerts ameliorates neurological injury, and regulates gut MC degranulation. However, there is limited research on the modulatory effect of VNS on MCs in both the gut and brain in brain ischemia-reperfusion (I/R) injury in this process. We aim to develop a minimally invasive, targeted and convenient VNS approach to assess the impact of VNS and to clarify the relationship between VNS and MCs on the prognosis of acute ischemic stroke. We utilized middle cerebral artery occlusion/reperfusion (MCAO/r) to induce brain I/R injury. After the experiment, the motor function and neurofunctional impairments of the rats were detected, and the gastrointestinal function, blood-brain barrier (BBB) and intestinal barrier damage, and systemic and local inflammation were evaluated by Nissl, TTC staining, Evans blue, immunofluorescence staining, transmission electron microscopy, western blot assays, ELISA, and fecal 16S rRNA sequencing methods. Our research confirmed that our minimally invasive VNS method is a novel approach for stimulating the vagus nerve. VNS alleviated motor deficits and gastrointestinal dysfunction while also suppressing intestinal and neuroinflammation. Additionally, VNS ameliorated gut microbiota dysbiosis in rats. Furthermore, our analysis indicated that VNS reduces chymase secretion by modulating MCs degranulation and improves intestinal and BBB damage. Our results showed that VNS treatment can alleviate the damage of BBB and colonic barrier after cerebral I/R by modulating mast cell degranulation, and alleviates systemic inflammatory responses.


Blood-Brain Barrier , Brain-Gut Axis , Cell Degranulation , Gastrointestinal Microbiome , Ischemic Stroke , Mast Cells , Rats, Sprague-Dawley , Reperfusion Injury , Vagus Nerve Stimulation , Animals , Mast Cells/immunology , Vagus Nerve Stimulation/methods , Male , Rats , Reperfusion Injury/therapy , Reperfusion Injury/immunology , Ischemic Stroke/therapy , Brain-Gut Axis/physiology , Infarction, Middle Cerebral Artery/therapy , Disease Models, Animal , Brain Ischemia/therapy , Brain Ischemia/immunology
2.
Pharmacol Res ; 175: 105994, 2022 01.
Article En | MEDLINE | ID: mdl-34808366

Although current evidence suggests that artemisinin and its derivatives play a multitarget therapeutic role in type 2 diabetes mellitus (T2DM), their efficacy and safety remain under debate. This meta-analysis aimed to evaluate the effects and safety of artemisinin and its derivatives in T2DM animal models. Preclinical studies that met the inclusion criteria were retrieved from PubMed, Embase, Web of Science, Scopus, CINAHL, OpenGrey, Google Scholar, Psyclnfo, British Library Ethos, ProQuest Dissertations & Theses, China National Knowledge Internet, VIP Information Chinese Periodical Service Platform, Chinese Biomedicine Literature Database, and Wanfang Data Knowledge Service Platform. Twenty-two studies involving 526 animals were included in the meta-analysis. The RevMan 5.3 and Stata 15.0, were used to perform the statistical analyses. The overall results showed that artemisinin or its derivatives could significantly reduce fasting plasma glucose, 2-h plasma glucose (2hPG) in the intraperitoneal glucose tolerance test (IPGTT), 2hPG in the intraperitoneal insulin tolerance test (IPITT), glycated hemoglobin A1c, under the curve in the IPGTT/IPITT, total cholesterol, triglyceride, low-density lipoprotein cholesterol, free fatty acid, and urine volume. Although increase in body weight was observed due to administration of the compounds, no significant effect was observed regarding serum insulin. In terms of adverse reactions, only two of the included studies reported that high-dose artemether may cause digestive inhibition in mice. Our results suggest that artemisinins could improve several parameters related to glycolipid metabolism in T2DM animal models. However, to evaluate the antidiabetic effects and safety of artemisinins in a more accurate manner, additional preclinical studies are necessary.


Artemisinins/therapeutic use , Diabetes Mellitus, Experimental/drug therapy , Diabetes Mellitus, Type 2/drug therapy , Hypoglycemic Agents/therapeutic use , Animals , Treatment Outcome
3.
Nat Chem ; 13(11): 1093-1100, 2021 11.
Article En | MEDLINE | ID: mdl-34635816

Chiral Brønsted acid-catalysed asymmetric synthesis has received tremendous interest over the past decades, and numerous efficient synthetic methods have been developed based on this approach. However, the use of chiral Brønsted acids in these reactions is mostly limited to the activation of imine and carbonyl moieties, and the direct activation of carbon-carbon triple bonds has so far not been invoked. Here we show that chiral Brønsted acids enable the catalytic asymmetric dearomatization reactions of naphthol-, phenol- and pyrrole-ynamides by the direct activation of alkynes. This method leads to the practical and atom-economic construction of various valuable spirocyclic enones and 2H-pyrroles that bear a chiral quaternary carbon stereocentre in generally good-to-excellent yields with excellent chemo-, regio- and enantioselectivities. The activation mode of chiral Brønsted acid catalysis revealed in this study is expected to be of broad utility in catalytic asymmetric reactions that involve ynamides and the related heteroatom-substituted alkynes.

4.
Org Biomol Chem ; 18(28): 5414-5419, 2020 Jul 22.
Article En | MEDLINE | ID: mdl-32618317

Transition metal-catalyzed single bond metathesis has recently emerged as a useful strategy for functional group transfer. In this work, we explored the mechanism and reactivity profile of Pd/PhI-cocatalyzed C-P bond metathesis between aryl phosphines using density functional theory (DFT) calculations. The overall single bond metathesis involves two Pd(ii)-catalyzed C-P reductive eliminations and two Pd(0)-catalyzed C-P oxidative additions, which allows the reversible C-P bond cleavage and formation of the phosphonium cation. Distortion/interaction analysis indicates that the facile C-P bond cleavage and formation of the phosphonium cation are due to the involvement of coordinating aryl phosphine in the process. In addition, the substituent effects on the reaction kinetics and thermodynamics of metathesis were computed, which provides helpful mechanistic information for the design of related single bond metathesis reactions.

5.
Angew Chem Int Ed Engl ; 58(45): 16252-16259, 2019 11 04.
Article En | MEDLINE | ID: mdl-31444882

Described herein is an organocatalytic enantioselective desymmetrizing cycloisomerization of arylsulfonyl-protected ynamide cyclohexanones, representing the first metal-free asymmetric Conia-ene-type carbocyclization. This method allows the highly efficient and atom-economical construction of a range of valuable morphans with wide substrate scope and excellent enantioselectivity (up to 97 % ee). In addition, such a cycloisomerization of alkylsulfonyl-protected ynamide cyclohexanones can lead to the divergent synthesis of normorphans as the main products with high enantioselectivity (up to 90 % ee). Moreover, theoretical calculations are employed to elucidate the origins of regioselectivity and enantioselectivity.

6.
Angew Chem Int Ed Engl ; 58(25): 8556-8560, 2019 06 17.
Article En | MEDLINE | ID: mdl-31046184

A new TiIII -mediated reductive epoxide-opening/ Beckwith-Dowd rearrangement process efficiently assembles the bicyclo[3.2.1]octane framework of highly oxidized grayanane diterpenoids. By incorporation of a Cu(tbs)2 -catalyzed (tbs=N-tert-butylsalicylaldiminato) intramolecular cyclopropanation, a diastereoselective oxidative dearomatization-induced Diels-Alder cycloaddition and a MeReO3 -catalyzed Rubottom oxidation, this approach has enabled the first total syntheses of rhodomolleins XX and XXII in 23 and 22 steps, respectively.

7.
Langmuir ; 32(38): 9846-53, 2016 09 27.
Article En | MEDLINE | ID: mdl-27595739

Control of interfacial properties (foaming and emulsification) plays an important role in industry. Here we developed a novel redox-responsive surfactant, 3-(11-benzylselanyl-undecyl)-dimethylammonium acetate (BSeUCB), using selenium atoms as an environmentally sensitive group. In a reduced state, BSeUCB aqueous solution showed good foaming and emulsification abilities as well as conventional betaine surfactants. After oxidization, BSeUCB transformed into a bola-type structure because of the presence of a new hydrophilic group (selenoxide), and thus the critical micellar concentration, equilibrium surface/interfacial tension, and molecular area at the interface correspondingly increase from 0.32 mM, 46.43 mN·m(-1), 5.30 mN·m(-1), and 0.61 nm(2) to 4.98 mM, 59.15 mN·m(-1), 18.29 mN·m(-1), and 1.22 nm(2), respectively, resulting in a greater amount of energy input required to produce foam or emulsion, and a less dense adsorption layer, i.e., poor foaming and emulsification ability. Such a conversion was reversibly controlled by simply adding a trace amount (<0.06 wt % of the dispersion) of oxidant (H2O2) and reductant (Na2SO3). The products of the redox reaction did not interfere in the switchability except at the first cycle. The oxidization was generally time-consuming, whereas the reduction was very fast.

...